These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 8135680

  • 1. Experimental studies of cis-diamminedichloroplatinum (II) and cis-diammine-1, 1-cyclobutandicarboxylate platinum (II) combination therapy for malignant gynecologic tumors.
    Kato N.
    Asia Oceania J Obstet Gynaecol; 1993 Dec; 19(4):467-76. PubMed ID: 8135680
    [Abstract] [Full Text] [Related]

  • 2. Combination treatment of cis- and carboplatin in cancers restricted to the peritoneal cavity in the rat.
    Los G, Tuyt L, van Vugt M, Schornagel J, Pinedo HM.
    Cancer Chemother Pharmacol; 1993 Dec; 32(6):425-33. PubMed ID: 8258189
    [Abstract] [Full Text] [Related]

  • 3. [Probability of the combination use of cisplatin and carboplatin].
    Kobayashi K, Hino M, Hayashihara K, Niitani H.
    Nihon Gan Chiryo Gakkai Shi; 1990 Nov 20; 25(11):2684-92. PubMed ID: 2277219
    [Abstract] [Full Text] [Related]

  • 4. Antitumor effects of three platinum complexes, (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato)-platinum (II) monohydrate (DWA2114R), cis-diammine-(1,1-cyclobutanedicarboxylato)platinum(II) (CBDCA) and cis-diamminedichloroplatinum(II) (CDDP), in mice.
    Endo K, Akamatsu K, Matsumoto T, Morikawa K, Koizumi M, Mitsui H, Koizumi K.
    Anticancer Res; 1992 Nov 20; 12(1):49-58. PubMed ID: 1567181
    [Abstract] [Full Text] [Related]

  • 5. [Pharmacokinetic analysis of platinum in the continuous CDDP-CBDCA treatment; its relation to the changes of blood biochemistry].
    Chen JT, Hasumi K.
    Gan To Kagaku Ryoho; 1995 Apr 20; 22(5):653-7. PubMed ID: 7717717
    [Abstract] [Full Text] [Related]

  • 6. Antitumor activity of cis-malonato[(4R,5R)-4,5-bis(aminomethyl)-2- isopropyl-1,3-dioxolane]platinum(II), a new platinum analogue, as an anticancer agent.
    Kim DK, Kim HT, Cho YB, Tai JH, Ahn JS, Kim TS, Kim KH, Hong WS.
    Cancer Chemother Pharmacol; 1995 Apr 20; 35(5):441-5. PubMed ID: 7850928
    [Abstract] [Full Text] [Related]

  • 7. Platinum agents in the treatment of osteosarcoma: efficacy of cisplatin vs. carboplatin in human osteosarcoma cell lines.
    Robson H, Meyer S, Shalet SM, Anderson E, Roberts S, Eden OB.
    Med Pediatr Oncol; 2002 Dec 20; 39(6):573-80. PubMed ID: 12376980
    [Abstract] [Full Text] [Related]

  • 8. In vitro antitumor activity of a new platinum complex, DWA2114R against human tumor cell lines.
    Akamatsu K, Saito H, Tsunenari T, Matsumoto T, Morikawa K, Koizumi M, Mitsui H, Koizumi K.
    Anticancer Res; 1993 Dec 20; 13(6A):2261-5. PubMed ID: 8297143
    [Abstract] [Full Text] [Related]

  • 9. In vitro interactions between platinum analogues in human ovarian-carcinoma cell lines.
    Perez RP, Perez KM, Handel LM, Hamilton TC.
    Cancer Chemother Pharmacol; 1992 Dec 20; 29(6):430-4. PubMed ID: 1568285
    [Abstract] [Full Text] [Related]

  • 10. Potentiation by interleukin 1 alpha of cisplatin and carboplatin antitumor activity: schedule-dependent and pharmacokinetic effects in the RIF-1 tumor model.
    Chang MJ, Yu WD, Reyno LM, Modzelewski RA, Egorin MJ, Erkmen K, Vlock DR, Furmanski P, Johnson CS.
    Cancer Res; 1994 Oct 15; 54(20):5380-6. PubMed ID: 7923169
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Similar effects of cis-diamminedichloroplatinum(II) and cis-diammine-1,1-cyclobutanedicarboxylatoplatinum(II) on sodium-coupled glucose uptake in renal brush-border membrane vesicles.
    Potdevin S, Courjault-Gautier F, Ripoche P, Toutain HJ.
    Arch Toxicol; 1998 Oct 15; 72(10):663-70. PubMed ID: 9851683
    [Abstract] [Full Text] [Related]

  • 13. [Phase I clinical study of combined cisplatin and carboplatin therapy in lung cancer].
    Hayasaka S, Yoshinaga T, Kinuwaki E, Kiyama T, Fujino N.
    Gan To Kagaku Ryoho; 1992 Oct 15; 19(12):2011-6. PubMed ID: 1417008
    [Abstract] [Full Text] [Related]

  • 14. Effect of tumor presence on cisplatin and carboplatin: disposition in the isolated, perfused tumor and skin flap.
    Vaden SL, Williams PL, Page RL, Riviere JE.
    Cancer Chemother Pharmacol; 1993 Oct 15; 32(1):31-8. PubMed ID: 8462121
    [Abstract] [Full Text] [Related]

  • 15. Increased therapeutic efficacy induced by tumor necrosis factor alpha combined with platinum complexes and whole-body hyperthermia in rats.
    Ohno S, Strebel FR, Stephens LC, Siddik ZH, Makino M, Klostergaard J, Tomasovic SP, Khokhar AR, Bull JM.
    Cancer Res; 1992 Aug 01; 52(15):4096-101. PubMed ID: 1638521
    [Abstract] [Full Text] [Related]

  • 16. Cyclophosphamide-cisplatin versus cyclophosphamide-carboplatin in stage III-IV ovarian carcinoma: a comparison of equally myelosuppressive regimens.
    Edmonson JH, McCormack GM, Wieand HS, Kugler JW, Krook JE, Stanhope CR, Everson LK, Laurie JA, Ebbert LP, Malkasian GD.
    J Natl Cancer Inst; 1989 Oct 04; 81(19):1500-4. PubMed ID: 2674460
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics and antitumor activity of a new platinum compound, cis-malonato[(4R,5R)-4,5-bis(aminomethyl)-2-isopropyl-1, 3- dioxolane]platinum(II), as determined by ex vivo pharmacodynamics.
    Kim DK, Kim HT, Tai JH, Cho YB, Kim TS, Kim KH, Park JG, Hong WS.
    Cancer Chemother Pharmacol; 1995 Oct 04; 37(1-2):1-6. PubMed ID: 7497577
    [Abstract] [Full Text] [Related]

  • 18. Potentiation of cis-diammine(1,1-cyclobutanedicarboxylato)platinum(II) by amphotericin B in BALB/c nude mice bearing human ovarian carcinoma cells.
    Kojima M, Kikkawa F, Oguchi H, Tamakoshi K, Maeda O, Suganuma N, Tomoda Y.
    Jpn J Cancer Res; 1994 Nov 04; 85(11):1159-64. PubMed ID: 7829402
    [Abstract] [Full Text] [Related]

  • 19. Synergism of cytotoxicity between cis-diaminedichloro-platinum-(ii) and cis-diamine(1,1-cyclobutanedicarboxylate)-platinum-(ii).
    Baba H, Maehara Y, Takeuchi H, Inutsuka S, Yamamoto M, Endo K, Sugimachi K.
    Int J Oncol; 1994 Feb 04; 4(2):329-33. PubMed ID: 21566928
    [Abstract] [Full Text] [Related]

  • 20. In vitro and in vivo antineoplastic activity of a new platinum antineoplastic agent, (R)-(-)-1,1-cyclobutanedicarboxylate (2-aminomethylpyrrolidine)-platinum (II) (DWA2114R) on freshly separated human tumor cells and human tumor xenografts transplanted in nude mice--a comparison with cis-diammine-dichloroplatinum (CDDP).
    Nio Y, Imai S, Shiraishi T, Tsubono M, Morimoto H, Tseng CC, Tobe T.
    Anticancer Res; 1991 Feb 04; 11(2):761-7. PubMed ID: 2064331
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.